Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Clinical trial NCT02004392 · TERMINATED
Trial details
- NCT number
- NCT02004392
- Sponsor
- FORUM Pharmaceuticals Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-08-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.